Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

Share Price is delayed by 15 minutes
Get Live Data
70.10    1.70 (2.49%)
Bid:
69.80
Ask:
70.20
Spread: 0.40 (0.573%)
Market Cap: $43.61b
AXB Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank Regs Share Chart

  • This share is an international stock.

Issue of Equity

18 Dec 2017 13:59

RNS Number : 6762Z
Axis Bank Limited
18 December 2017
Β 

AXIS/CO/CS/726/2017-18

18th December 2017

Β 

Dear Sir,

SUB: ALLOTMENT OF EQUITY SHARES AND WARRANTS ON A PREFERENTIAL BASIS

Β 

REF: REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENT) REGULATIONS 2015.

Β 

This has reference to our letters AXIS/CO/CS/597/2017-18 dated 10th November 2017 and AXIS/CO/CS/685/2017-18 dated 8th December 2017, wherein we had informed you regarding outcome of the Board Meeting held on 10th November 2017 and outcome of the Extraordinary General Meeting of the Shareholders of the Bank held on 8th December 2017, respectively.

Β 

We are pleased to inform that the Committee of Whole-time Directors of the Bank at its meeting held today has pursuant to receipt of the consideration, approved the issuance and allotment of:

Β 

Β· 5,56,00,000 equity shares of face value of Rs. 2/- each (the "Investor 1 Equity Shares") to BC Asia Investments VII Limited (the "Investor 1"), on a preferential basis at a price of Rupees 525 per Equity Share.

Β 

Β· 3,19,00,000 equity shares of face value of Rs. 2/- each (the "Investor 2 Equity Shares") to Integral Investments South Asia IV (the "Investor 2"), on a preferential basis at a price of Rupees 525 per Equity Share.

Β 

Β· 4,00,00,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 3 Convertible Warrants") to BC Asia Investments III Limited (the "Investor 3"), on a preferential basis at a price of Rupees 565 per warrant.

Β 

Β· 59,98,000 equity shares of face value of Rs. 2/- each (the "Investor 4 Equity Shares") to New World Fund, Inc. (the "Investor 4"), on a preferential basis at a price of Rupees 525 per Equity Share.

Β 

Β· 2,26,884 equity shares of face value of Rs. 2/- each (the "Investor 5 Equity Shares") to Capital Group New World Fund (LUX) (the "Investor 5"), on a preferential basis at a price of Rupees 525 per Equity Share.

Β 

Β· 53,08,000 equity shares of face value of Rs. 2/- each (the "Investor 6 Equity Shares") to American Funds Insurance Series - International Fund (the "Investor 6"), on a preferential basis at a price of Rupees 525 per Equity Share

Β 

Β· 4,28,72,967 equity shares of face value of Rs. 2/- each (the "Investor 7 Equity Shares") to EuroPacific Growth Fund (the "Investor 7"), on a preferential basis at a price of Rupees 525 per Equity Share

Β 

Β· 5,65,899 equity shares of face value of Rs. 2/- each (the "Investor 8 Equity Shares") to American Funds Insurance Series - International Growth and Income Fund (the "Investor 8"), on a preferential basis at a price of Rupees 525 per Equity Share

Β 

Β· 27,86,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 4 Convertible Warrants") to Investor 4, on a preferential basis at a price of Rupees 565 per warrant.

Β 

Β· 1,05,385 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 5 Convertible Warrants") to Investor 5, on a preferential basis at a price of Rupees 565 per warrant.

Β 

Β· 24,66,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 6 Convertible Warrants") to Investor 6, on a preferential basis at a price of Rupees 565 per warrant.

Β 

Β· 2,28,57,142 equity shares of face value of Rs. 2/- each (the "Promoter Investor Equity Shares") to Life Insurance Corporation of India (the "Promoter Investor"), on a preferential basis at a price of Rupees 525 per Equity Share.

Β 

Pursuant to the allotment of the said equity shares, the total issued and paid up share capital of the Bank has increased from Rs. 479,71,01,600 (239,85,50,800 equity shares of Rs. 2/- each) to Rs. 512,77,59,384 (256,38,79,692 equity shares of Rs. 2/- each).

Β 

Please note that the Equity Shares allotted on a preferential basis as aforesaid rank pari passu with the existing equity shares of the Bank, in all respects.

Β 

Further, the equity shares and convertible warrantsΒ shall be under lock-in for such period as prescribed under the SEBI (Issue of Capital and Disclosures Requirement) Regulations, 2009.

Β 

You are requested to take note the above and arrange to bring it to the notice of all concerned.

Β 

Thanking you.

Β 

Yours Sincerely,

For Axis Bank Limited

Β 

Β 

Β 

Girish V Koliyote

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOEGGGAAPUPMGWR
Date   Source Headline
26th Apr 20183:16 pmRNSApproval for Grant of Stock Options
26th Apr 20182:52 pmRNSAnnual Financial Results
9th Apr 20183:04 pmRNSRegulation 30 of SEBI (LODR) Requirements, 2018
28th Mar 20189:44 amRNSESOP Allotment details
22nd Jan 20189:06 amRNS3rd Quarter Results
10th Jan 20181:11 pmRNSQUARTERLY REPORTING - ALLOT. OF EQ. SH. UNDER ESOP
20th Dec 20171:51 pmRNSNotice of Results
19th Dec 20177:00 amRNSAPPOINTMENT OF ADDITIONAL NON-EXECUTIVE DIRECTOR
18th Dec 20171:59 pmRNSIssue of Equity
8th Dec 201711:46 amRNSReappointment of MD & CEO
8th Dec 201711:40 amRNSOutcome of EGM
14th Nov 20178:37 amRNSNotice of Extraordinary General Meeting
10th Nov 20171:20 pmRNSPress release - Raising of Funds
10th Nov 201711:51 amRNSOutcome of Board Meeting - Raising of Funds
7th Nov 20172:52 pmRNSNotice of Board Meeting - Raising of Funds
17th Oct 201712:09 pmRNSHalf-year Results
11th Oct 20172:08 pmRNSDirectorate Change - CESSATION
6th Oct 20174:00 pmRNSDISCLOSURE IN TERMS OF REGULATION 30 OF SEBI LODR
26th Sep 201710:54 amRNSQUARTERLY REPORTING - ALLOT. OF SHARES UNDER ESOP
14th Sep 201712:18 pmRNSNotice of Results
1st Sep 20177:00 amRNSInformation on Bank's exposure to select accounts
3rd Aug 20179:56 amRNSFinal Terms for issue of 500,000,000 Notes
31st Jul 201712:24 pmRNSPublication of Offering Circular - 28 July 2017
31st Jul 201711:52 amRNSAnnual Report for the Financial Year 2016-17
27th Jul 201711:42 amRNSRe-appointment of Smt Shikha Sharma as MD and CEO
27th Jul 201711:34 amRNSAcquisition
27th Jul 20178:10 amRNSAcquisition
25th Jul 201712:17 pmRNS1st Quarter Results
30th Jun 20171:58 pmRNSQUARTERLY REPORTING-ALLOT. OF EQ. SH. UNDER ESOP
29th Jun 20177:00 amRNSINFORMATION ON BANK'S EXPOSURE TO SELECT ACCOUNTS
28th Jun 20173:14 pmRNSIssue of Debt
15th Jun 20172:28 pmRNSIssue of Debt
15th May 201710:04 amRNSAPPROVAL OF GRANT OF STOCK OPTIONS
26th Apr 20175:10 pmRNSBOARD OUTCOME AXIS BANK LIMITED
26th Apr 20171:21 pmRNSFinal Results
31st Mar 20171:31 pmRNSQUARTERLY REPORTING:ALLOTMENT OF SHARES UNDER ESOP
27th Mar 20173:07 pmRNSAXIS RAISES SENIOR NOTES IN INTERNATIONAL MARKET
22nd Mar 20172:11 pmRNSAXIS RAISES SENIOR NOTES IN INTERNATIONAL MARKET
22nd Mar 201712:51 pmRNSNotice of Results
20th Feb 20177:00 amRNSNews clarification
9th Feb 20179:20 amRNSNews Clarification
2nd Feb 201712:34 pmRNSBank Raises Senior Notes in International Market
19th Jan 20172:56 pmRNS3rd Quarter Results
28th Dec 20167:00 amRNSQUARTERLY REPORTING - ALLOTMENT OF ESOP
19th Dec 20169:12 amRNSNotice of Results
9th Dec 20162:34 pmRNSAcquisition
25th Oct 20161:24 pmRNSResult of Meeting
17th Oct 201612:20 pmRNSREDEMPTION OF US$46,000,000 7.167%CALLABLE HYBRID
27th Sep 20164:35 pmRNSAllotment of Equity Shares under ESOP
21st Sep 20162:39 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.